Phenergan and Simponi drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Phenergan (promethazine hydrochloride) and Simponi (golimumab). Common drug interactions include drug hypersensitivity among females and acute respiratory distress syndrome among males.
The phase IV clinical study analyzes what interactions people have when they take Phenergan and Simponi. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.
What is Phenergan?
Phenergan has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 25,312 Phenergan users. Check the latest studies of Phenergan.
What is Simponi?
Simponi has active ingredients of golimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 86,328 Simponi users. Check the latest studies of Simponi.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
77 people who take Phenergan and Simponi together, and have interactions are studied.

What are the common drug interactions of Phenergan and Simponi, by gender? *:
female:
- Drug hypersensitivity
- Arthritis infective (purulent invasion of a joint by an infectious agent which produces arthritis)
- Pruritus (severe itching of the skin)
- Abdominal pain
- Appetite disorder (abnormal eating habits)
- Arthralgia (joint pain)
- Asthenia (weakness)
- Back pain
- Chills (felling of cold)
- Constipation
male:
- Acute respiratory distress syndrome
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Diarrhoea infectious (bacteria, viruses, and other germs can cause diarrhoea)
- Hodgkin's disease (cancer originating from white blood cells)
- Interstitial lung disease
- Gastrointestinal inflammation (inflammation of stomach and intestine)
- Pneumonia
- Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
- Cardiac failure
- Pain in extremity
What are the common drug interactions of Phenergan and Simponi, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Drug ineffective
- Malaise (a feeling of general discomfort or uneasiness)
30-39:
- Pain in extremity
40-49:
- Meningitis viral (viral inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
- Gastrointestinal inflammation (inflammation of stomach and intestine)
- Hypersensitivity
- Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
- Migraine (headache)
- Pneumonia
- Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
50-59:
- Acute respiratory distress syndrome
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Diarrhoea infectious (bacteria, viruses, and other germs can cause diarrhoea)
- Hodgkin's disease (cancer originating from white blood cells)
- Interstitial lung disease
- Mass
- Nasopharyngitis (inflammation of the nasopharynx)
- Otitis media (inflammation of the middle ear)
- Pyrexia (fever)
- Sinusitis (inflammation of sinus)
60+:
- Drug hypersensitivity
- Abdominal pain
- Diarrhoea
- Dysphagia (a condition in which swallowing is difficult or painful)
- Dysphoria (generalized dissatisfaction with life)
- Ear pain
- Erythema (redness of the skin)
- Fatigue (feeling of tiredness)
- Gait disturbance
- Haemorrhagic diathesis (bleeding tendency)
What are the existing conditions these people have? *
- Dizziness: 47 people, 61.04%
- Pain: 16 people, 20.78%
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 6 people, 7.79%
- High Blood Pressure: 6 people, 7.79%
- Sleep Disorder: 4 people, 5.19%
- High Blood Cholesterol: 4 people, 5.19%
* Approximation only. Some reports may have incomplete information.
Do you take Phenergan and Simponi?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Phenergan and Simponi:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Phenergan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Simponi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Phenergan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Simponi and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
- Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on promethazine hydrochloride and golimumab (the active ingredients of Phenergan and Simponi, respectively), and Phenergan and Simponi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Amlodipine Besylate And Benazepril Hydrochloride cause Gastroesophageal Reflux Disease? - now
- Could Esomeprazole Sodium cause Acne? - 2 seconds ago
- Could Nabumetone cause Aortic Stenosis? - 3 seconds ago
- Could Escitalopram cause Swelling? - 10 seconds ago
- Could Escitalopram Oxalate cause Communication Disorder? - 20 seconds ago
- Ankylosing Spondylitis and Multi-Organ Disorder - 22 seconds ago
- Anaplastic Astrocytoma and Insomnia - 26 seconds ago
- Anaesthesia and Dizziness - 28 seconds ago
- Could Theo-Dur cause Idiopathic Pulmonary Fibrosis? - 32 seconds ago
- Adult T-Cell Lymphoma/Leukaemia and Infusion Related Reaction - 40 seconds ago